Endobronchial Valves Market Size Worth $321.53 Million By 2034 | CAGR: 6.0%
The global endobronchial valves market size is expected to reach USD 321.53 million by 2034, according to a new study by Polaris Market Research. The report “Endobronchial Valves Market Share, Size, Trends, Industry Analysis Report, By Product Type (Duckbill-Shaped, Umbrella-Shaped); By End User; By Region; Segment Forecast, 2026 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Endobronchial valves are gaining importance nowadays due to the rising prevalence of emphysema and chronic obstructive pulmonary disease (COPD) in the world. It is a minimally invasive surgery in which the placement of this device is done to assist COPD patients in breathing. The ongoing treatment offered by various health centers and institutions is driving research and development activities to grow. For instance, in May 2023, Hackensack University Medical Centre announced its new treatment for emphysema by offering Minimally Invasive Zephyr Endobronchial Valve Treatment, which received initial approval from the FDA in 2018 for the treatment of homogeneous and heterogeneous emphysema patients. It assists the patients in breathing freely by enabling the air to go out of the damaged part of the lungs.
The increasing number of research studies focusing on reviewing the advancements in endobronchial valves is expected to assist researchers in designing advanced endobronchial valves. As an example, in October 2023, a study published in PubMed Central focused on reviewing the developments in treating COPD. In cluster analysis, the emphysema bronchoscopic lung volume reduction treatment using a single endobronchial valve device for hyperinflation and severe breathlessness patients showed to be effective in the long term with positive survival benefits compared to the non-treated patients. These research studies are embarking on new growth opportunities by revealing the potential benefits of endobronchial valve devices in the global space.
Request a free sample copy or read the full market insights : Endobronchial Valves Market report
Most of the researchers are working on measuring the effectiveness of endobronchial valve treatment with a view to improving patients health outcomes. A study published in the Respiratory Medicine Journal in April 2023 focused on finding the impact of lung volume reduction using endobronchial valve treatment on patients' survival. The study witnessed 8.2 years of average survival after the treatment, along with improvements in pulmonary function, exercise capacity, and quality of life. The continuous rise in medical studies, particularly lungs-related devices, are in favor of building trust among patients to have a clear idea of how it affects their health after having the treatment, contributing to increased awareness about the bronchial valves in the marketplace.
Endobronchial Valves Market Report Highlights
- Duckbill-Shaped segment is anticipated to witness the highest growth in the coming years due to its rising adoption among manufacturers due to its effectiveness.
- Hospitals segment accounted for the largest market share owing to the increased use by pulmonologists driven by rising COPD cases.
- North America is expected to witness the largest growth rate in the study period, highly influenced by the growing number of lung-related health issues in the region.
- Asia Pacific will grow rapidly, owing to the increasing elderly population, followed by a significant rise in tuberculosis and influenza cases in the region.
- The global players include Boston Scientific Corporation, Broncus Medical, EndoStim, Olympus Corporation, PneumRx, Pulmonx Corporation & Spiration.
Polaris Market Research has segmented the endobronchial valves market report based on product type, end user and region:
Endobronchial Valves, Product Type Outlook (Revenue - USD Million, 2021 - 2034)
- Duckbill-shaped
- Umbrella-shaped
Endobronchial Valves, End User Outlook (Revenue - USD Million, 2021 - 2034)
- Hospitals
- Clinical Research Center
- Ambulatory Surgery Center
- Others
Endobronchial Valves, Regional Outlook (Revenue - USD Million, 2021 - 2034)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Endobronchial Valves Market Report Scope
| Report Attributes | Details |
| Market size value in 2025 | USD 190.64 million |
| Revenue forecast in 2034 | USD 321.53 million |
| CAGR | 6.0% from 2026 – 2034 |
| Base year | 2025 |
| Historical data | 2021 – 2024 |
| Forecast period | 2026 – 2034 |
| Quantitative units | Revenue in USD million and CAGR from 2026 to 2034 |
| Segments covered | By Product Type, By End User, By Region |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Customization | Report customization as per your requirements with respect to countries, region, and segmentation. |
| For Specific Research Requirements |
